Mitochondrial Gene Therapy Passes Final U.K. Vote
By Gretchen Vogel,
Science Insider
| 02. 24. 2015
[Quotes CGS's Marcy Darnovsky]
Untitled Document
The United Kingdom’s House of Lords has approved legislation to allow a new type of in vitro fertilization (IVF) that would replace faulty DNA, preventing certain types of genetic diseases. The vote follows the House of Commons approval of the measure on 3 February, making the United Kingdom the first country to explicitly allow the procedure, which would combine DNA from two biological parents and an egg donor.
The technique will be allowed under fairly tight regulation: Researchers who wish to offer the service to couples still must apply for and receive a license from the country’s Human Fertilisation and Embryology Authority.
The technique, called mitochondrial DNA replacement therapy, would allow women who have mutations in the DNA of their mitochondria, the organelles that provide chemical energy for cells, to have genetically related children who don’t carry the mutations. It is controversial, however, because it would modify the DNA of an embryo in a way that could be passed on to future generations.
People who have faulty mitochondria can experience a variety of symptoms, including heart problems...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Emily Mullin, Wired | 04.23.2026
A STARTUP OUT of Utah, Paterna Biosciences, says it has successfully grown functional human sperm in a lab and used the sperm to make visibly healthy-looking embryos. The technique could eventually help men with certain types of infertility have biological children...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...
By Fyodor D. Urnov and Sadik H. Kassim, Nature | 04.21.2026
In February, the US Food and Drug Administration (FDA) proposed a radical rethink of how scientists, physicians and manufacturers develop personalized genetic therapies. The regulator’s suggested introduction of a ‘plausible mechanism pathway’ should increase incentives for drug companies to develop...